Defining the role of IL-21/IL-21R signaling in RA is important because of the interest in blocking this pathway therapeutically by targeting IL-21, IL-21R (56) and the Janus kinases (JAK) (57, 58). This evidence concerns the gene IL21 and rheumatoid arthritis.